These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 30098028)

  • 1. Use of ticagrelor alongside fibrinolytic therapy in patients with ST-segment elevation myocardial infarction: Practical perspectives based on data from the TREAT study.
    Berwanger O; Abdelhamid M; Alexander T; Alzubaidi A; Averkov O; Aylward P; Contreras Zúñiga E; Halvorsen S; Iglesias R; A Sk Abdul Kader M; Zubaid M; AlHabib KF
    Clin Cardiol; 2018 Oct; 41(10):1322-1327. PubMed ID: 30098028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiographic outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes).
    Kunadian V; James SK; Wojdyla DM; Zorkun C; Wu J; Storey RF; Steg PG; Katus H; Emanuelsson H; Horrow J; Maya J; Wallentin L; Harrington RA; Gibson CM
    JACC Cardiovasc Interv; 2013 Jul; 6(7):671-83. PubMed ID: 23866179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ticagrelor or clopidogrel dual antiplatelet therapy following a pharmacoinvasive strategy in ST-segment elevation myocardial infarction.
    Welsh RC; Shavadia JS; Zheng Y; Tyrrell BD; Leung R; Bainey KR
    Clin Cardiol; 2021 Nov; 44(11):1543-1550. PubMed ID: 34405422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial.
    Berwanger O; Lopes RD; Moia DDF; Fonseca FA; Jiang L; Goodman SG; Nicholls SJ; Parkhomenko A; Averkov O; Tajer C; Malaga G; Saraiva JFK; Guimaraes HP; de Barros E Silva PGM; Damiani LP; Santos RHN; Paisani DM; Miranda TA; Valeis N; Piegas LS; Granger CB; White HD; Nicolau JC
    J Am Coll Cardiol; 2019 Jun; 73(22):2819-2828. PubMed ID: 30898608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: a systematic review and meta-analysis of randomized clinical trials.
    Kheiri B; Osman M; Abdalla A; Haykal T; Barbarawi M; Zayed Y; Hicks M; Ahmed S; Bachuwa G; Hassan M; Bhatt DL
    J Thromb Thrombolysis; 2018 Oct; 46(3):299-303. PubMed ID: 29934940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ticagrelor versus clopidogrel on platelet function in fibrinolytic-treated STEMI patients undergoing early PCI.
    Dehghani P; Lavoie A; Lavi S; Crawford JJ; Harenberg S; Zimmermann RH; Booker J; Kelly S; Cantor WJ; Mehta SR; Bagai A; Goodman SG; Cheema AN
    Am Heart J; 2017 Oct; 192():105-112. PubMed ID: 28938956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: Rationale and design of the ticagrelor in patients with ST elevation myocardial infarction treated with thrombolysis (TREAT) trial.
    Berwanger O; Nicolau JC; Carvalho AC; Jiang L; Goodman S; Nicholls SJ; Parkhomenko A; Averkov O; Tajer C; Malaga G; Kerr Saraiva JF; Fonseca F; Guimaraes HP; de Barros E Silva PGM; Damiani LP; Paisani DM; Lasagno CMR; Candido CT; Valeis N; Moia DDF; Piegas LS; Granger CB; White H; Lopes RD
    Am Heart J; 2018 Aug; 202():89-96. PubMed ID: 29908420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term efficacy of ticagrelor in acute ST-segment elevation myocardial infarction patients undergoing an emergency percutaneous coronary intervention.
    Cao B; Qu F; Liu X; Gao C; Fu Q; Jiang C; Wei P; Ma Q
    Aging (Albany NY); 2019 Oct; 11(20):8925-8936. PubMed ID: 31665124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis.
    Wang Z; Zhou DY; Su Y; Si LY; Xu Q
    BMC Cardiovasc Disord; 2020 Mar; 20(1):130. PubMed ID: 32164560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study.
    Gibson CM; Murphy SA; Pride YB; Kirtane AJ; Aroesty JM; Stein EB; Ciaglo LN; Southard MC; Sabatine MS; Cannon CP; Braunwald E;
    Am Heart J; 2008 Jan; 155(1):133-9. PubMed ID: 18082504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-Morphine.
    Lapostolle F; Van't Hof AW; Hamm CW; Stibbe O; Ecollan P; Collet JP; Silvain J; Lassen JF; Heutz WMJM; Bolognese L; Cantor WJ; Cequier A; Chettibi M; Goodman SG; Hammett CJ; Huber K; Janzon M; Merkely B; Storey RF; Ten Berg J; Zeymer U; Licour M; Tsatsaris A; Montalescot G;
    Am J Cardiovasc Drugs; 2019 Apr; 19(2):173-183. PubMed ID: 30353444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial.
    Berwanger O; Nicolau JC; Carvalho AC; Jiang L; Goodman SG; Nicholls SJ; Parkhomenko A; Averkov O; Tajer C; Malaga G; Saraiva JFK; Fonseca FA; De Luca FA; Guimaraes HP; de Barros E Silva PGM; Damiani LP; Paisani DM; Lasagno CMR; Candido CT; Valeis N; Moia DDF; Piegas LS; Granger CB; White HD; Lopes RD;
    JAMA Cardiol; 2018 May; 3(5):391-399. PubMed ID: 29525822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial.
    Van de Werf F; Ristić AD; Averkov OV; Arias-Mendoza A; Lambert Y; Kerr Saraiva JF; Sepulveda P; Rosell-Ortiz F; French JK; Musić LB; Vandenberghe K; Bogaerts K; Westerhout CM; Pagès A; Danays T; Bainey KR; Sinnaeve P; Goldstein P; Welsh RC; Armstrong PW;
    Circulation; 2023 Aug; 148(9):753-764. PubMed ID: 37439219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction.
    Armstrong PW; Gershlick AH; Goldstein P; Wilcox R; Danays T; Lambert Y; Sulimov V; Rosell Ortiz F; Ostojic M; Welsh RC; Carvalho AC; Nanas J; Arntz HR; Halvorsen S; Huber K; Grajek S; Fresco C; Bluhmki E; Regelin A; Vandenberghe K; Bogaerts K; Van de Werf F;
    N Engl J Med; 2013 Apr; 368(15):1379-87. PubMed ID: 23473396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ticagrelor versus clopidogrel in real-world patients with ST elevation myocardial infarction: 1-year results by propensity score analysis.
    Vercellino M; Sànchez FA; Boasi V; Perri D; Tacchi C; Secco GG; Cattunar S; Pistis G; Mascelli G
    BMC Cardiovasc Disord; 2017 Apr; 17(1):97. PubMed ID: 28381298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors on Top of Ticagrelor in STEMI: A Subanalysis of the ATLANTIC Trial.
    Tavenier AH; Hermanides RS; Fabris E; Lapostolle F; Silvain J; Ten Berg JM; Lassen JF; Bolognese L; Cantor WJ; Cequier Á; Chettibi M; Goodman SG; Hammett CJ; Huber K; Janzon M; Merkely B; Storey RF; Zeymer U; Ecollan P; Collet JP; Willems FF; Diallo A; Vicaut E; Hamm CW; Montalescot G; van 't Hof AWJ;
    Thromb Haemost; 2020 Jan; 120(1):65-74. PubMed ID: 31752042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ticagrelor versus clopidogrel in patients with STEMI treated with thrombolysis: the MIRTOS trial.
    Hamilos M; Kanakakis J; Anastasiou I; Karvounis C; Vasilikos V; Goudevenos J; Michalis L; Koutouzis M; Tsiafoutis I; Raisakis K; Stakos D; Hahalis G; Vardas P;
    EuroIntervention; 2021 Feb; 16(14):1163-1169. PubMed ID: 32715996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of a pharmacoinvasive strategy for successful versus failed fibrinolysis and primary percutaneous intervention in acute myocardial infarction (from the STrategic Reperfusion Early After Myocardial Infarction [STREAM] study).
    Welsh RC; Van de Werf F; Westerhout CM; Goldstein P; Gershlick AH; Wilcox RG; Danays T; Bluhmki E; Lopes RD; Steg PG; Armstrong PW
    Am J Cardiol; 2014 Sep; 114(6):811-9. PubMed ID: 25108302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Ticagrelor in Comparison to Clopidogrel in Elderly Patients With ST-Segment-Elevation Myocardial Infarctions.
    Schmucker J; Fach A; Mata Marin LA; Retzlaff T; Osteresch R; Kollhorst B; Hambrecht R; Pohlabeln H; Wienbergen H
    J Am Heart Assoc; 2019 Sep; 8(18):e012530. PubMed ID: 31538856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.